loadpatents
name:-0.025162935256958
name:-0.0088469982147217
name:-0.0092020034790039
Golden; Pam Patent Filings

Golden; Pam

Patent Applications and Registrations

Patent applications and USPTO patent grants for Golden; Pam.The latest application filed is for "solid dispersion forms of rifaximin".

Company Profile
8.9.27
  • Golden; Pam - Durham NC
  • - Durham NC US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Solid dispersion forms of rifaximin
Grant 11,311,521 - Golden , et al. April 26, 2
2022-04-26
Solid Dispersion Forms Of Rifaximin
App 20220040157 - Golden; Pam ;   et al.
2022-02-10
Solid Dispersion Forms Of Rifaximin
App 20210401813 - Golden; Pam ;   et al.
2021-12-30
Solid dispersion forms of rifaximin
Grant 11,129,817 - Golden , et al. September 28, 2
2021-09-28
Solid Dispersion Forms Of Rifaximin
App 20210205279 - Golden; Pam ;   et al.
2021-07-08
Solid dispersion forms of rifaximin
Grant 10,874,647 - Golden , et al. December 29, 2
2020-12-29
Formulations Of Rifaximin And Uses Thereof
App 20200397904 - Selbo; Jon ;   et al.
2020-12-24
Methods For Retreating Irritable Bowel Syndrome (ibs)
App 20200276170 - Golden; Pam ;   et al.
2020-09-03
Methods For Retreating Irritable Bowel Syndrome (ibs)
App 20200230116 - Golden; Pam ;   et al.
2020-07-23
Methods for retreating irritable bowel syndrome (IBS)
Grant 10610522 -
2020-04-07
Methods For Treating Infection
App 20200069664 - Du Pont; Herbert L. ;   et al.
2020-03-05
IBS microbiota and uses thereof
Grant 10,493,064 - Golden , et al. De
2019-12-03
Solid Dispersion Forms Of Rifaximin
App 20190224175 - Golden; Pam ;   et al.
2019-07-25
Formulations Of Rifaximin And Uses Thereof
App 20170333562 - Selbo; Jon ;   et al.
2017-11-23
Formulations of rifaximin and uses thereof
Grant 9,737,610 - Selbo , et al. August 22, 2
2017-08-22
Rifaximin derivative and uses thereof
Grant 9,725,466 - Golden , et al. August 8, 2
2017-08-08
Ibs Microbiota And Uses Thereof
App 20170151220 - Golden; Pam ;   et al.
2017-06-01
Methods For Retreating Irritable Bowel Syndrome (ibs)
App 20170105977 - Golden; Pam ;   et al.
2017-04-20
Formulations Of Rifaximin And Uses Thereof
App 20170087134 - Golden; Pam ;   et al.
2017-03-30
Rifaximin Derivative And Uses Thereof
App 20160257700 - Golden; Pam ;   et al.
2016-09-08
Rifaximin derivative and uses thereof
Grant 9,364,467 - Golden , et al. June 14, 2
2016-06-14
Rifaximin Derivative And Uses Thereof
App 20150342934 - Golden; Pam ;   et al.
2015-12-03
Rifaximin derivative and uses thereof
Grant 9,035,046 - Golden , et al. May 19, 2
2015-05-19
Method Of Treating Ulcerative Colitis
App 20150132284 - Forbes; William P. ;   et al.
2015-05-14
Formulations Of Rifaximin And Uses Thereof
App 20150133482 - Selbo; Jon ;   et al.
2015-05-14
Rifaximin Derivative And Uses Thereof
App 20140378495 - Golden; Pam ;   et al.
2014-12-25
Methods Of Treating Ulcerative Colitis
App 20140349982 - Forbes; William ;   et al.
2014-11-27
Method For Treating Ulcerative Colitis
App 20140349983 - Forbes; William P. ;   et al.
2014-11-27
Methods And Compositions For Treating Hiv-associated Diarrhea
App 20140163096 - Golden; Pam ;   et al.
2014-06-12
Methods For Treating Infection
App 20130210852 - DuPont; Herbert L. ;   et al.
2013-08-15
Methods For Treating Irritable Bowel Syndrome (ibs) And Infections
App 20130184302 - Bortey; Enoch ;   et al.
2013-07-18
Formulations Of Rifaximin And Uses Thereof
App 20120077835 - Selbo; Jon ;   et al.
2012-03-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed